The company’s upcoming earnings report date is not yet available.
Is Cannonau overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Cannonau pay dividends?
Cannonau does not currently pay dividends.
What is Cannonau’s EPS estimate?
Cannonau’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannonau have?
Cannonau has 241,377,180 shares outstanding.
Which hedge fund is a major shareholder of Cannonau?
Currently, no hedge funds are holding shares in CNNC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cannonau
Cannonau Corp. specializes in the development and marketing of products based on cannabidiol. The company, which was established in 2007, previously operated as Pacific Blue Energy Corp. before officially rebranding to Cannonau Corp. in August 2019. Its operations are headquartered in Skaneateles, New York.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Markwin Maring
Employees
4
Website
pbec.biz
Address
937 Old Senecca Turnpike Road, Skaneateles, NY, 13252-9318, US